Olfactory Biosciences Corp. cancelled the transaction announced on May 2, 2017	02.05.18
Olfactory Biosciences Corp. Announces New NOXO Sensory Spectrum Disorders Gel	23.08.17
Olfactory Biosciences Corp. announced that it expects to receive $3 million in funding	02.05.17
OLFY BIOS : OLFC Announces Revolutionary Topical Non-Prescription Natural Medicines for Anxiety, Stress, Sensory issues and Other Common Conditions -- An Answer to Today's Health Care Debacle	15.01.15

Manager	Titel	Alter	Seit
Richard Stevenson CEO	Chief Executive Officer	-	-
Sidney J. Pine DFI	Director of Finance/CFO	-	-
Gregory Van Alfen SAM	Sales & Marketing	-	-

Aufsichtsräte	Titel	Alter	Seit
Sidney J. Pine DFI	Director of Finance/CFO	-	-

Unternehmensprofil

Sektor